CN102453036B - A kind of camptothecine compounds and preparation method thereof and the purposes in agricultural chemicals - Google Patents
A kind of camptothecine compounds and preparation method thereof and the purposes in agricultural chemicals Download PDFInfo
- Publication number
- CN102453036B CN102453036B CN201010520770.0A CN201010520770A CN102453036B CN 102453036 B CN102453036 B CN 102453036B CN 201010520770 A CN201010520770 A CN 201010520770A CN 102453036 B CN102453036 B CN 102453036B
- Authority
- CN
- China
- Prior art keywords
- camptothecine
- compound
- agricultural chemicals
- compounds
- purposes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000003905 agrochemical Substances 0.000 title claims abstract description 13
- 239000001301 oxygen Substances 0.000 claims abstract description 31
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 31
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- 241000196324 Embryophyta Species 0.000 claims abstract description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000004936 Bromus mango Nutrition 0.000 claims abstract description 9
- 235000014826 Mangifera indica Nutrition 0.000 claims abstract description 9
- 235000009184 Spondias indica Nutrition 0.000 claims abstract description 9
- 241000162439 Brontispa longissima Species 0.000 claims abstract description 7
- 241000985245 Spodoptera litura Species 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 240000007228 Mangifera indica Species 0.000 claims abstract description 6
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 5
- 240000001592 Amaranthus caudatus Species 0.000 claims abstract description 4
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims abstract description 4
- 244000178993 Brassica juncea Species 0.000 claims abstract description 4
- 235000012735 amaranth Nutrition 0.000 claims abstract description 4
- 239000004178 amaranth Substances 0.000 claims abstract description 4
- 235000005855 Brassica juncea var. subintegrifolia Nutrition 0.000 claims abstract description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- -1 isobutyl- Chemical group 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 14
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-Lutidine Substances CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 239000005864 Sulphur Substances 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims description 4
- 238000004440 column chromatography Methods 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 241001529387 Colletotrichum gloeosporioides Species 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 208000031888 Mycoses Diseases 0.000 claims 2
- 238000012360 testing method Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 7
- XAKLYHGHEFMDAP-IAXKEJLGSA-N drf-1042 Chemical compound C1=CC=C2C=C(C(OCCO)N3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 XAKLYHGHEFMDAP-IAXKEJLGSA-N 0.000 abstract description 6
- 239000004009 herbicide Substances 0.000 abstract description 6
- 230000003013 cytotoxicity Effects 0.000 abstract description 5
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 5
- 230000000452 restraining effect Effects 0.000 abstract description 4
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 10
- 239000004471 Glycine Substances 0.000 description 10
- 229940127093 camptothecin Drugs 0.000 description 10
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 10
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 8
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000007795 chemical reaction product Substances 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 229940126559 Compound 4e Drugs 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 229940125907 SJ995973 Drugs 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 229940125782 compound 2 Drugs 0.000 description 6
- 229940125872 compound 4d Drugs 0.000 description 6
- 229940126115 compound 4f Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000002045 lasting effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 125000004344 phenylpropyl group Chemical group 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000009333 weeding Methods 0.000 description 4
- 241001093152 Mangifera Species 0.000 description 3
- BLSQLHNBWJLIBQ-OZXSUGGESA-N (2R,4S)-terconazole Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2N=CN=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 BLSQLHNBWJLIBQ-OZXSUGGESA-N 0.000 description 2
- PNHBRYIAJCYNDA-VQCQRNETSA-N (4r)-6-[2-[2-ethyl-4-(4-fluorophenyl)-6-phenylpyridin-3-yl]ethyl]-4-hydroxyoxan-2-one Chemical compound C([C@H](O)C1)C(=O)OC1CCC=1C(CC)=NC(C=2C=CC=CC=2)=CC=1C1=CC=C(F)C=C1 PNHBRYIAJCYNDA-VQCQRNETSA-N 0.000 description 2
- VIMMECPCYZXUCI-MIMFYIINSA-N (4s,6r)-6-[(1e)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one Chemical compound CN1N=NN=C1C(\C=C\[C@@H]1OC(=O)C[C@@H](O)C1)=C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 VIMMECPCYZXUCI-MIMFYIINSA-N 0.000 description 2
- QOLHWXNSCZGWHK-BWBORTOCSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-(11-phenoxyundecylcarbamoyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@@H]([C@@H](OC(=O)NCCCCCCCCCCCOC=3C=CC=CC=3)C(O1)(C(O)=O)C(O)(C(O2)C(O)=O)C(O)=O)O)C1=CC=CC=C1 QOLHWXNSCZGWHK-BWBORTOCSA-N 0.000 description 2
- MOQCFMZWVKQBAP-UHFFFAOYSA-N 1-[3,5-bis(trifluoromethyl)benzoyl]-n-(4-chlorophenyl)piperidine-3-carboxamide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C(=O)N2CC(CCC2)C(=O)NC=2C=CC(Cl)=CC=2)=C1 MOQCFMZWVKQBAP-UHFFFAOYSA-N 0.000 description 2
- AKBHYCHPWZPGAH-UHFFFAOYSA-N 2-[3-[(3-chloro-4-methylphenyl)methoxy]azetidine-1-carbonyl]-7-oxa-5-azaspiro[3.4]octan-6-one Chemical compound CC1=C(Cl)C=C(COC2CN(C2)C(=O)C2CC3(C2)COC(=O)N3)C=C1 AKBHYCHPWZPGAH-UHFFFAOYSA-N 0.000 description 2
- 241000759905 Camptotheca acuminata Species 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 238000006424 Flood reaction Methods 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-Phenylalanine Natural products OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- PQLFROTZSIMBKR-UHFFFAOYSA-N ethenyl carbonochloridate Chemical compound ClC(=O)OC=C PQLFROTZSIMBKR-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229940089256 fungistat Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- XZMHJYWMCRQSSI-UHFFFAOYSA-N n-[5-[2-(3-acetylanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]benzamide Chemical compound CC(=O)C1=CC=CC(NC=2SC=C(N=2)C2=C(N=C(NC(=O)C=3C=CC=CC=3)S2)C)=C1 XZMHJYWMCRQSSI-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- RWWYLEGWBNMMLJ-YSOARWBDSA-N remdesivir Chemical compound NC1=NC=NN2C1=CC=C2[C@]1([C@@H]([C@@H]([C@H](O1)CO[P@](=O)(OC1=CC=CC=C1)N[C@H](C(=O)OCC(CC)CC)C)O)O)C#N RWWYLEGWBNMMLJ-YSOARWBDSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FUXVKZWTXQUGMW-FQEVSTJZSA-N 9-Aminocamptothecin Chemical compound C1=CC(N)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 FUXVKZWTXQUGMW-FQEVSTJZSA-N 0.000 description 1
- 0 CC[C@@](*1)(C=*1C*=*(C)C1)C(C=C(C2=N3)N4C(COCCOC(C(N)NC(C(C5(C)C)=CC(C)(C)N5N)=O)=O)C2=*CC3=*C=CCC=*)=C1C4=O Chemical compound CC[C@@](*1)(C=*1C*=*(C)C1)C(C=C(C2=N3)N4C(COCCOC(C(N)NC(C(C5(C)C)=CC(C)(C)N5N)=O)=O)C2=*CC3=*C=CCC=*)=C1C4=O 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 241000222233 Colletotrichum musae Species 0.000 description 1
- 244000152970 Digitaria sanguinalis Species 0.000 description 1
- 235000010823 Digitaria sanguinalis Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000209018 Nyssaceae Species 0.000 description 1
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- LNHWXBUNXOXMRL-VWLOTQADSA-N belotecan Chemical compound C1=CC=C2C(CCNC(C)C)=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 LNHWXBUNXOXMRL-VWLOTQADSA-N 0.000 description 1
- 229950011276 belotecan Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229950009429 exatecan Drugs 0.000 description 1
- ZVYVPGLRVWUPMP-FYSMJZIKSA-N exatecan Chemical compound C1C[C@H](N)C2=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC3=CC(F)=C(C)C1=C32 ZVYVPGLRVWUPMP-FYSMJZIKSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960004768 irinotecan Drugs 0.000 description 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- RVFGKBWWUQOIOU-NDEPHWFRSA-N lurtotecan Chemical compound O=C([C@]1(O)CC)OCC(C(N2CC3=4)=O)=C1C=C2C3=NC1=CC=2OCCOC=2C=C1C=4CN1CCN(C)CC1 RVFGKBWWUQOIOU-NDEPHWFRSA-N 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 231100001224 moderate toxicity Toxicity 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229930002341 quinoline alkaloid Natural products 0.000 description 1
- VHXNKPBCCMUMSW-FQEVSTJZSA-N rubitecan Chemical compound C1=CC([N+]([O-])=O)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VHXNKPBCCMUMSW-FQEVSTJZSA-N 0.000 description 1
- 229950009213 rubitecan Drugs 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 229960000303 topotecan Drugs 0.000 description 1
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The present invention relates to the camptothecine compounds that a class is new, and the preparation method of this compound and the purposes in agricultural chemicals.The preparation method of this compound is by <i>N</iGreatT.Gr eaT.GT-(1 ˊ-oxygen base-2 ˊ, 2 ˊ, 5 ˊ, 5 ˊ-tetramethyl-pyrroles-acid amides)-3 ˊ-<i>L</iGreatT.Gr eaT.GT-amino acid and 5-hydroxyethyl oxygen camptothecine react under proper catalyst and dewatering agent effect, purified separation and get final product.By the desinsection to this compounds, bacteriostasis and herbicides active testing, prove that such Compound Phase has good cytotoxicity for camptothecine and DRF-1042 to Agricultural pests (as Brontispa longissima, prodenia litura), to phytopathogen (as mango anthracnose and mango blossom-end rot) and farmland weed (as lady's-grass, leaf mustard and three-coloured amaranth), there is good restraining effect.
Description
Technical field
The present invention relates to a kind of new camptothecine compounds, and the preparation method of this compound and preparing the purposes in agricultural chemicals.Belong to pesticide field.
Background technology
Camptothecine (Camptothecin) be Wall equal 1966 first from the distinctive Nyssaceae plant camptotheca acuminata of China (
camptothecaacuminata) in be separated a kind of quinoline alkaloid of obtaining, its have anticancer, antiviral, desinsection and the multiple biological activity such as antibacterial (
j.Nat.Prod. 2004, 67,129-135).Mainly anti-tumor aspect is laid particular emphasis on both at home and abroad to the research of camptothecine, conduct in-depth research in its chemosynthesis and structural modification, anticancer structure activity relationship, the mechanism of action etc., wherein multiple active compound such as irinotecan, topotecan, 9-aminocamptothecin, 9-nitrocamptothecin, DX-8951f, GG-211 and CKD-602 etc. are gone on the market by FDA approval or are in clinical investigation phase (1.
bioorg.Med.Chem.
2004,
12, 1585 – 1604; 2.
phytochem. 2004,
65, 2735 – 2749).
In recent years, camptothecine crude extract and simple derivatives be used to prepare sterilant or fungistat (
j.Agric.FoodChem. 2005, 53, 32-37, US20020018762(2002), CN100384329(2005), CN101518250(2009), CN1843128(2006), CN100579372(2006)).But exist when camptothecine crude extract and simple derivatives are used for preparing sterilant or fungistat and be easy to decompose, the lasting period of losing efficacy is short, poorly water-soluble and not easily make the shortcomings such as preparation.
The present invention utilizes principle of hybridization nitroxyl free radical to be passed through
l-amino acid connects 5 formation camptothecin esters in camptothecine, the a series of structure of design and synthesis is not easily decomposed, the inefficacy lasting period extends, the new camptothecine compounds of water-soluble raising, also improve medicine agricultural (comprising desinsection, bacteriostasis and herbicides) active simultaneously, and facilitate the preparation of this compounds on pesticide preparation.
Summary of the invention
The invention provides the camptothecine compounds that a class is new.Another object of the present invention provides the preparation method of this kind of new compound and the purposes at pesticide field thereof simultaneously.
Technical scheme of the present invention is that to have agricultural (comprising desinsection, bacteriostasis and herbicides) preferably according to camptothecine active, but it has moderate toxicity, and nitroxyl free radical and
l-amino acid has the advantage such as biological activity widely, significantly improving bioactive while, can greatly reduce its toxicity.Therefore, nitroxyl free radical is passed through by the present invention
l-amino acid connects 5 formation camptothecin esters in camptothecine, synthesize and a series ofly not easily to decompose, the inefficacy lasting period extends, the camptothecine compounds of water-soluble raising, agricultural (the comprising desinsection, bacteriostasis and herbicides) of improving this compounds active simultaneously, facilitates the preparation of this compounds on pesticide preparation simultaneously.
The object of the invention is to be realized by following measures:
Camptothecine compounds of the present invention refers to have the compound shown in following general formula (I):
(I)
(I) in formula, R is hydrogen, methyl, first sulphur methylene radical, sec.-propyl, butyl, isobutyl-, β-indole methyl or benzyl.
The preparation method of compound of the present invention be by 5-hydroxyethyl oxygen camptothecine with
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-amino acid is dissolved in dry methylene dichloride; stir under nitrogen protection; then dicyclohexylcarbodiimide (DCC) is added; stirring reaction under nitrogen protection; removing white precipitate is refiltered after question response completes, after removing solvent under reduced pressure, crude by column chromatography purifying; with the chloroform-methanol wash-out that volume ratio is 40:1, obtain product.
5-hydroxyethyl oxygen camptothecine 1mmol is dissolved in 50mL methylene dichloride by the best preparation method of compound of the present invention, adds 1mmol's
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-amino-acid compound, under nitrogen protection with N, N-lutidine as catalyzer, and the dicyclohexylcarbodiimide (DCC) adding equivalent is dewatering agent, reacts and carries out at room temperature condition.
Desinsection, bacteriostasis and herbicides Activity determination show, the compound of formula (I) has desinsection, bacteriostasis and herbicides is active, therefore the invention provides the purposes of camptothecine compounds in preparation control plant disease pest and weed medicine.
beneficial effect of the present invention:
Camptothecine compounds novel structure of the present invention, be easy to synthesis, have and not easily decompose, the inefficacy lasting period extends, the feature of water-soluble raising, relative to camptothecine and DRF-1042, good restraining effect is all shown to phytopathogen, Agricultural pests and farmland weed, is easy to make all kinds of pesticide preparation, the environment friendly agricultural that its exploitation is stable, efficient, nontoxic can be utilized.Have broad application prospects.
Below by way of embodiment, foregoing of the present invention is described in further detail.But this should be interpreted as limitation of the present invention.
Embodiment
embodiment 1
Camptothecine compounds preparation process
Preparation method of the present invention be by 5-hydroxyethyl oxygen camptothecine (compound 2) with
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-amino acid (3a-3h) is dissolved in dry methylene dichloride, adds catalytic amount
n,N-lutidine; stir 5 minutes under nitrogen protection; then dicyclohexylcarbodiimide (DCC) is added; stirring reaction 2 hours under nitrogen protection; cross and filter white precipitate, after removing solvent under reduced pressure, crude by column chromatography purifying; with the chloroform-methanol wash-out that volume ratio is 40:1, obtain formula I (4a-4h).
Relevant reaction is see reaction formula 1.
reaction formula 1
R in formula 1 is hydrogen, methyl, first sulphur methylene radical, sec.-propyl, butyl, isobutyl-, β-indole methyl or benzyl.
Intermediate therefor raw material 5-hydroxyethyl oxygen camptothecine (compound 2) of the present invention is for raw material is at FeCl by camptothecine (compound 1)
3/ H
2sO
4/ OHCH
2cH
2oH reaction system obtains, and its method therefor is see (Subrahmanyam, D.etal, US6177439 (2001)), and correlated response is shown in formula 1.
embodiment 2
The present invention is used
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-amino acid (
3a-3h) obtained by following method:
3-carboxyl-2,2,5,5-tetramethyl-pyrroles-nitroxyl free radical (compound 5,9.2g, 0.05mol) and triethylamine (5.05g, 0.05mol) are dissolved in 100mL anhydrous diethyl ether, under agitation mixture are cooled to 0 DEG C.Slow dropping Vinyl chloroformate (5.42g, 0.05mol), at room temperature stirs 3h by mixture after dropwising, and filters, by filtrate evaporate to dryness, uses sherwood oil recrystallization, obtain glassy yellow needle-like crystal
6, productive rate 90%.By gained compound
6(10.25g, what 0.04mol) join stirring immediately is dissolved with sodiumazide (3.88g, in 75mL acetone 0.06mol) and the mixing solutions of water, 30min is stirred under ice bath, then n-hexane extraction is used, extraction liquid anhydrous sodium sulfate drying, removal of solvent under reduced pressure, debris is cooled to-20 DEG C, obtains yellow crystals
7, productive rate 93%.Triazo-compound is prepared into by above-mentioned
7(2.09g, 0.01mol) is dissolved in 20mL diox, is joined and is dissolved with in 0.01mol amino acid and the magnesian 10mL aqueous solution of 0.8g, temperature controls at 40 DEG C, stir 24h, then also use anhydrous sodium sulfate drying with chloroform extraction, steaming desolventizes purifying and obtains
n-(1-oxygen base-2,2,5,5-tetramethyl-pyrroles-acid amides)-
l-amino acid (
3a-3h), productive rate: 50 ~ 60%.Method therefor see literature method (Hideg, K.etal,
synthesis,
1978, 914-916).
Its reaction is see following formula (reaction formula 2)
Reaction formula 2
R in its reaction formula is hydrogen, methyl, first sulphur methylene radical, sec.-propyl, butyl, isobutyl-, β-indole methyl or benzyl.
5-hydroxyethyl oxygen camptothecine 1mmol is dissolved in 20mL methylene dichloride by best preparation method of the present invention, adds 1mmol's
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-amino-acid compound, under nitrogen protection with
n,N-lutidine is as catalyzer, and the dicyclohexylcarbodiimide (DCC) adding equivalent is dewatering agent, reacts and carries out at room temperature condition.
Below provide the embodiment of the present invention
embodiment 3
5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-glycine] camptothecin ester (
4a) synthesis
By 3-carboxyl-2,2,5,5-tetramethyl-pyrroles-nitroxyl free radical
(compound 5)(9.2g, 0.05mol) and triethylamine (5.05g, 0.05mol) are dissolved in 100mL anhydrous diethyl ether, under agitation mixture are cooled to 0 DEG C.Slow dropping Vinyl chloroformate (5.42g, 0.05mol), at room temperature stirs 3h by mixture after dropwising, and filters, by filtrate evaporate to dryness, uses sherwood oil recrystallization,
compound 6, forglassy yellow needle-like crystal, 11.6g, productive rate 90%, fusing point: 63-65 DEG C.
By compound
6(10.25g, what 0.04mol) join stirring immediately is dissolved with sodiumazide (3.88g, in 75mL acetone 0.06mol) and the mixing solutions of water, 30min is stirred under ice bath, then n-hexane extraction is used, extraction liquid anhydrous sodium sulfate drying, removal of solvent under reduced pressure, debris is cooled to-20 DEG C, obtains compound
7, foryellow crystals, 7.8g, productive rate 93%, fusing point: 62-63 DEG C.
By the above-mentioned compound 7(2.09g be prepared into, 0.01mol) be dissolved in 20mL diox, joined and be dissolved with in 0.01mol amino acid and the magnesian 10mL aqueous solution of 0.8g, temperature controls at 40 DEG C, stir 24h, then also use anhydrous sodium sulfate drying with chloroform extraction, steaming desolventizes purifying and obtains
n-(1-oxygen base-2,2,5,5-tetramethyl-pyrroles-acid amides)-
l-amino acid (compound 3a-3h), productive rate: 50 ~ 60%.This reactions steps is with reference to Hideg, K.etal,
synthesis,
1978, the method that 914-916 reports.
Intermediate therefor raw material 5-hydroxyethyl oxygen camptothecine of the present invention is that raw material is at FeCl by camptothecine
3/ H
2sO
4/ OHCH
2cH
2oH reaction system obtains, and its method therefor is see (Subrahmanyam, D.etal, US6177439 (2001).
By 1mmol5-hydroxyethyl oxygen camptothecine and 1mmol
n-(1-oxygen base-2,2,5,5-tetramethyl-pyrroles-acid amides)-
l-glycine is dissolved in the methylene dichloride of 20mL drying; add 0.1 gram of N of catalytic amount; N-lutidine, stirs 5 minutes under nitrogen protection, then adds 0.21 gram of dicyclohexylcarbodiimide (DCC); stirring reaction 2 hours under nitrogen protection; cross and filter white precipitate, after removing solvent under reduced pressure, crude by column chromatography purifying; with the chloroform-methanol wash-out that volume ratio is 40:1, obtain 5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-glycine] camptothecin ester (compound 4a).
The detection data of product (compound 4a) are as follows:
Productive rate: 90%; M.p.115-117; IR (KBr) υ cm
-1: 3346 (NH), 1715 (NHCO), 3062,1626,1490 (ArH), 1662 (C=O), 1242,1155,1090 (C-O), 1364 (NO
. ); MS (EI) m/z:632 (M+1); HRMSC
33h
35n
4o
9: theoretical value (M+H): 632.2477, measured value: 632.2481; ESR:g
0=2.0055, A
n=14.62Gs (tripletpeakin1 × 10
-4m, DMF).
embodiment 4
5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-l-Ala] camptothecin ester (compound
4b) synthesis:
Experimental procedure and embodiment 1 together, only replace glycine with L-Ala.Reaction products therefrom is compound
4b,detection data are as follows:
Productive rate: 86%; M.p.120-122 DEG C; IR (KBr) υ cm
-1: 3429 (NH), 1743 (NHCO), 3056,1624,1552 (ArH), 1662 (C=O), 1087,1156,1231 (C-O), 1362 (NO
. ); MS (EI) m/z:646 (M+1); HRMSC
34h
37n
4o
9: theoretical value (M+H): 646.2633, measured value: 646.2625; ESR:g
0=2.0058, A
n=14.62Gs (tripletpeakin1 × 10
-4m, DMF).
embodiment 5
5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-methionine(Met)] camptothecin ester (compound
4c) synthesis
Experimental procedure and embodiment 1 together, only replace the glycine of embodiment 1 with methionine(Met).Reaction products therefrom (compound
4c) detect data as follows:
Productive rate: 82%; M.p.155-157; IR (KBr) υ cm
-1: 3423 (NH), 1711 (NHCO), 3060,1625,1563 (ArH), 1663 (C=O), 1088,1153,1236 (C-O), 1362 (NO
. ); MS (EI) m/z:706 (M+1); HRMSC
36h
41n
4o
9s: theoretical value (M+H): 706.2267, measured value: 706.2656; ESR:g
0=2.0055, A
n=14.62Gs (tripletpeakin1 × 10
-4m, DMF).
embodiment 6
5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-isoleucine] synthesis of camptothecin ester (compound 4d)
Experimental procedure and embodiment 1 together, only replace the glycine of embodiment 1 with Isoleucine.It is as follows that reaction products therefrom (compound 4d) detects data:
Productive rate: 75%; M.p.160-162; IR (KBr) υ cm
-1: 3423 (NH), 1746 (NHCO), 3091,1621,1562 (ArH), 1664 (C=O), 1114,1155,1228 (C-O), 1359 (NO
. ); MS (EI) m/z:688 (M+1); HRMSC
37h
43n
4o
9: theoretical value (M+H): 688.3103, measured value: 688.3098; ESR:g
0=2.0055, A
n=14.62Gs (tripletpeakin1 × 10
-4m, DMF).
embodiment 7
5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-phenylalanine] camptothecin ester (compound
4e) synthesis
Experimental procedure and embodiment 1 together, only replace the glycine of embodiment 1 with phenylalanine.Reaction products therefrom (compound
4e) detect data as follows:
Productive rate: 87%; 142-144 DEG C; IR (KBr) υ cm
-1: 3425 (NH), 1744 (NHCO), 3093,1623,1564 (ArH), 1664 (C=O), 1113,1153,1234 (C-O), 1361 (NO
. ); MS (EI) m/z:722 (M+1); HRMSC
40h
41n
4o
9: theoretical value (M+H): 722.2946, measured value: 722.2944; ESR:g
0=2.0055, A
n=14.62Gs (tripletpeakin1 × 10
-4m, DMF).
embodiment 8
5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-leucine] camptothecin ester (compound
4f) synthesis
Experimental procedure and embodiment 1 together, only replace the glycine of embodiment 1 with leucine.Reaction products therefrom (compound
4f) detect data as follows:
Productive rate: 68%; M.p.117-119; IR (KBr) υ cm
-1: 3418 (NH), 1747 (NHCO), 3065,1621,1562 (ArH), 1664 (C=O), 1114,1157,1227 (C-O), 1359 (NO
. ); MS (EI) m/z:688 (M+1); HRMSC
37h
43n
4o
9: theoretical value (M+H): 688.3103, measured value: 688.3110; ESR:g
0=2.0055, A
n=14.62Gs (tripletpeakin1 × 10
-4m, DMF).
embodiment 9
5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-α-amino-isovaleric acid] camptothecin ester (compound
4g) synthesis
Experimental procedure and embodiment 1 together, only replace the glycine of embodiment 1 with α-amino-isovaleric acid.Reaction products therefrom (compound
4g) detect data as follows:
Productive rate: 76%; M.p.120-122; IR (KBr) υ cm
-1: 3416 (NH), 1750 (NHCO), 3092,1620,1538 (ArH), 1665 (C=O), 1106,1157,1231 (C-O), 1359 (NO
. ); MS (EI) m/z:674 (M+1); HRMSC
36h
41n
4o
9 :theoretical value (M+H): 674.2946, measured value: 674.2956; ESR:g
0=2.0055, A
n=14.62Gs (tripletpeakin1 × 10
-4m, DMF).
embodiment 10
5-O-second hydroxyl-[
n-(1'-oxygen base-2', 2', 5', 5'-tetramethyl-pyrroles-acid amides)-3'-
l-tryptophane] camptothecin ester (compound
4h) synthesis
Experimental procedure and embodiment 1 together, only replace the glycine of embodiment 1 with tryptophane.Reaction products therefrom (compound
4h) detect data as follows:
Productive rate: 54%; M.p.127-129; IR (KBr) υ cm
-1: 3413 (NH), 1745 (NHCO), 3061,1619,1522 (ArH), 1663 (C=O), 1086,1158,1229 (C-O), 1356 (NO
. ); MS (EI) m/z:761 (M+1); HRMSC
42h
42n
5o
9 :theoretical value (M+H): 761.3055, measured value: 761.3040; ESR:g
0=2.0055, A
n=14.62Gs (tripletpeakin1 × 10
-4m, DMF).
embodiment 11
camptothecine compounds 4a-4h is to the inhibit activities of phytopathogen
for examination bacterial classification:mango Stem-rot isolate
botryodiplodiatheobromaepat., Colletotrichum gloeosporioides Penz in Mango
colletotrichumgloeosporioidespenz, Glorosprium musarum Cookeet Mass
colletotrichummusae(Berk.etCurt.) Arx provides by Research Institute of Environment and Plant Protection, Chinese Academy of Tropi.
reagent agent:medicine is compound
4a-4h(preparing according to embodiment 1), camptothecine and 5-hydroxyethyl oxygen camptothecine product in contrast.
test method: test employing growth rate method (Mu Liyi. chemical protection of plant research method. Chinese agriculture press .1987:79-81).Concrete operations are as follows:
1. bacterial classification prepares: in culture dish, pour 10mLPDA substratum (or capsicum epidemic disease Radix Dauci Sativae substratum) into, under aseptic condition, a mycelia block is got from for examination germ inclined-plane, be placed in the middle of culture dish, cultured continuously several generations, test and inoculate once in first 3 days, under thermophilic, darkroom is cultivated for subsequent use, ensures the vigor of bacterial classification.
2. supply reagent liquid: the acetone that test compound is dissolved in, be mixed with the acetone soln of 1mg/mL for examination.
3. make bacterium cake: under aseptic condition, appropriate bacterium cake will be got for examination bacterial classification 0.4cm punch tool for subsequent use.
4. the preparation of medicine substratum is with: after a series of gradient concentration being diluted to for reagent liquid, prepare to draw a certain amount of (1mL) liquid and inject correspondence markings tool plug scale test tube, pour the PDA dissolved or other substratum (9mL) more while hot into, (now liquor strength is diluted 10 times and is not affected solidifying of substratum), firmly shake up rapidly, pour in correspondence markings culture dish immediately, make thin and thick evenly dull and stereotyped, three repetitions are done in each process, two classes are established in contrast, one class is respectively poured in three culture dish with pure culture base 10mL and is connect bacterium, observes after three days, only for referencial use; Another kind ofly add 9ml substratum with 1mL acetone and respectively pour in three culture dish, within after connecing bacterium three days, check statistics.
5. will be placed on plate culture medium for examination bacterium cake carefully with inoculating needle, mycelia faces down, three pieces, every ware or one piece, is equidistantly triangular in shapely put in central authorities, then adds a cover mark, and under putting thermophilic, darkroom is cultivated.
6. result inspection: cultivate in dark after 72 hours (or being determined on a case-by-case basis), take out, use kind of calliper colony diameter, twice statistical average is got in right-angled intersection.Note, above-mentioned sequence of operations must be carried out under stringent asepsis requirements.
Colony growth diameter (mm)=twice diameter mean value-4.0(bacterium cake diameter)
Table 1 embodiment camptothecine compounds is at the bacteriostatic activity of 50mg/L to 3 kinds of germs
Note: third-compound 4b, different bright-compound 4d, bright-compound 4f, egg-compound 4c, figured silk fabrics-compound 4g, look-compound 4h, sweet-compound 4a, phenylpropyl alcohol-compound 4e, DRF-1042 compound 2, camptothecine-compound 1.
Conclusion: as shown in Table 1, camptothecine compounds has good restraining effect to mango Stem-rot isolate, Colletotrichum gloeosporioides Penz in Mango, Glorosprium musarum Cookeet Mass, especially comparatively obvious to mango Stem-rot isolate restraining effect.
embodiment 12
the insecticidal activity of camptothecine compounds 4a-4h
for examination insect:prodenia litura 4 instar larvae is that the Folium Ricini of non-dispenser from Chinese Academy of Tropical Agricultural Sciences's environment and Plant Protection Institute test base is adopted back, in indoor feeding breeding many generations, and the larva confession examination in 4 mid-terms in age of picking Individual Size, solid colour during test.Brontispa longissima 5 instar larvae is adopt back from Danzhou, Hainan coconut palm, in indoor feeding breeding many generations, and the larva confession examination in 5 mid-terms in age of picking Individual Size, solid colour during test.
reagent agent:medicine is compound
4a-4h(preparing according to embodiment 1), camptothecine and 5-hydroxyethyl camptothecine product in contrast.
prodenia litura sod cultivation:test employing leaf dipping method (Mu Liyi. chemical protection of plant research method. Chinese agriculture press .1987:56).First above sample acetone is settled to 2mg/mL, tests using 1mg/mL as screening concentration.Folium Ricini is put into respectively after each confession reagent liquid floods 3s and take out, put on thieving paper and dry, then prodenia litura 4 instar larvae consistent for Individual Size is put into the culture dish that process blade is housed, at the bottom of culture dish, be covered with filter paper moisturizing.Culture dish is placed in incubator (T:25 ± 1 DEG C, RH=70 ~ 80%) to cultivate.Compare with acetone, every concentration repeats 3 times, often repeats 10 cephalonts.Examination worm turns hello normal blade after feeding and being with malicious blade 2d, and worm takes food and death condition in quantitative check examination, touches polypide, be considered as death with complete motionless person with writing brush.Add up dead borer population respectively at 3d, 6d and 9d, calculate mortality ratio and corrected mortality, its test result is in table 2
Table 2 embodiment camptothecine compounds at 1mg/mL to the cytotoxicity to Spodoptera litura larvae
Note: third-compound 4b, different bright-compound 4d, bright-compound 4f, egg-compound 4c, figured silk fabrics-compound 4g, look-compound 4h, sweet-compound 4a, phenylpropyl alcohol-compound 4e, DRF-1042 compound 2, camptothecine-compound 1.
brontispa longissima sod cultivation:test employing leaf dipping method (Mu Liyi. chemical protection of plant research method. Chinese agriculture press .1987:56).First above sample acetone is settled to 1mg/mL, tests using 0.1mg/mL as screening concentration.Coconut leaf is put into respectively after each confession reagent liquid floods 3s and take out, put on thieving paper and dry, then Brontispa longissima larva consistent for Individual Size is put into the culture dish that process blade is housed, at the bottom of culture dish, be covered with filter paper moisturizing.Culture dish is placed in incubator (T:25 ± 1 DEG C, RH=70 ~ 80%) to cultivate.Compare with acetone, every concentration repeats 3 times, often repeats 10 cephalonts.Examination worm turns hello normal blade after feeding and being with malicious blade 2d, and quantitative check examination worm death condition, touches polypide with writing brush, be considered as death with complete motionless person.Add up dead borer population respectively at 3d, 6d and 9d, calculate mortality ratio and corrected mortality, its test result is in table 3.
Table 3 embodiment camptothecine compounds is at the cytotoxicity of 0.1mg/mL to Brontispa longissima 5 instar larvae
Note: third-compound 4b, different bright-compound 4d, bright-compound 4f, egg-compound 4c, figured silk fabrics-compound 4g, look-compound 4h, sweet-compound 4a, phenylpropyl alcohol-compound 4e, DRF-1042 compound 2, camptothecine-compound 1.
Conclusion: from table 2 and table 3, camptothecine compounds all has cytotoxicity in various degree to Brontispa longissima, prodenia litura, and wherein part of compounds has significant cytotoxicity to this two class examination worm.
embodiment 13
the weeding activity of camptothecine compounds 4a-4h
for examination weeds:leaf mustard
brassicajuncea(being purchased from Danzhou City seeds company), three-coloured amaranth
amaranthusmangostanusl.(is purchased from Danzhou City seeds company), lady's-grass
digitariasanguinalis(L.) Scop.(picks up from ring and plants tested base).After measured, seed nature germination rate is all more than 95% for all seeds.
reagent agent:medicine is compound
4a-4h(preparing according to embodiment 1), camptothecine and 5-hydroxyethyl camptothecine product in contrast.
test method: reference farm-chemical indoor determination test rule (People's Republic of China's agricultural industry criteria. farm-chemical indoor determination test rule. weedicide), compound is mixed with the acetone soln that mass concentration is 1000mg/L, draw 1mL liquid to add and be covered with in the 90mm culture dish of filter paper, after acetone volatilization is dry, add the 2mL0.1% tween-80 aqueous solution, dilution obtains the aqueous solution of 500mg/L (0.5mg/mL), then 10, the seed just sprouted fitly is arranged in culture dish, build preservative film, often process and repeat for 3 times, then be placed in growth cabinet and cultivate (daytime 28 DEG C ± 2 DEG C, evening 24 DEG C ± 2 DEG C, relative humidity 75% ± 5%), with the 0.1% tween-80 aqueous solution for blank.Root length and the bud of measuring lady's-grass after 3-6d are respectively long, and the root length of leaf mustard and three-coloured amaranth and plumular axis length, press formulae discovery weeding activity below, it the results are shown in Table 4.
Inhibiting rate (%)=
Table 4 embodiment camptothecine compounds is at the weeding activity of 0.5mg/mL
Note: third-compound 4b, different bright-compound 4d, bright-compound 4f, egg-compound 4c, figured silk fabrics-compound 4g, look-compound 4h, sweet-compound 4a, phenylpropyl alcohol-compound 4e, DRF-1042 compound 2, camptothecine-compound 1.
Conclusion: as shown in Table 4, camptothecine compounds all has weeding activity in various degree to 3 kinds of farmland weeds.。
Claims (9)
1. a camptothecine compounds, is characterized in that its chemical general formula is for the compounds shown in (I) formula:
(I)
Wherein in (I) formula, R is hydrogen, methyl, first sulphur methylene radical, sec.-propyl, butyl, isobutyl-, β-indole methyl or benzyl.
2. the preparation method of a camptothecine compounds as claimed in claim 1; it is characterized in that 5-hydroxyethyl oxygen camptothecine and N-(1-oxygen base-2; 2; 6; 6-tetramethyl piperidine-oxygen-carbonyl)-L-amino acid is dissolved in dry methylene dichloride; stir under nitrogen protection; then dicyclohexylcarbodiimide (DCC) is added; stirring reaction under nitrogen protection; removing white precipitate is refiltered after question response completes, after removing solvent under reduced pressure, crude by column chromatography purifying; with the chloroform-methanol wash-out that volume ratio is 40:1, obtain product.
3. the preparation method of a camptothecine compounds as claimed in claim 1; 5-hydroxyethyl oxygen camptothecine 1mmol is it is characterized in that to be dissolved in 50mL methylene dichloride; add N-(the 1-oxygen base-2 of 1mmol; 2,6,6-tetramethyl piperidine-oxygen-carbonyl)-L-amino-acid compound; under nitrogen protection with N; N-lutidine is as catalyzer, and the dicyclohexylcarbodiimide (DCC) adding equivalent is dewatering agent, reacts and carries out at room temperature condition.
4. the purposes of camptothecine compounds as claimed in claim 1 in agricultural chemicals, is characterized in that it can apply in the agricultural chemicals of preparation control fungal diseases of plants.
5. the purposes of a kind of camptothecine compounds according to claim 4 in agricultural chemicals, is characterized in that described fungal diseases of plants is Colletotrichum gloeosporioides Penz in Mango, mango Stem-rot isolate and Glorosprium musarum Cookeet Mass.
6. the purposes of camptothecine compounds as claimed in claim 1 in agricultural chemicals, is characterized in that it can apply in the agricultural chemicals of preparation control Agricultural pests.
7. the purposes of a kind of camptothecine compounds according to claim 6 in agricultural chemicals, is characterized in that described Agricultural pests are Brontispa longissima, prodenia litura.
8. the purposes of camptothecine compounds as claimed in claim 1 in agricultural chemicals, is characterized in that it can apply in the agricultural chemicals of preparation control farmland weed.
9. the purposes of a kind of camptothecine compounds according to claim 8 in agricultural chemicals, is characterized in that described farmland weed is lady's-grass, leaf mustard and three-coloured amaranth.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010520770.0A CN102453036B (en) | 2010-10-27 | 2010-10-27 | A kind of camptothecine compounds and preparation method thereof and the purposes in agricultural chemicals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010520770.0A CN102453036B (en) | 2010-10-27 | 2010-10-27 | A kind of camptothecine compounds and preparation method thereof and the purposes in agricultural chemicals |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102453036A CN102453036A (en) | 2012-05-16 |
CN102453036B true CN102453036B (en) | 2015-12-02 |
Family
ID=46036761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010520770.0A Expired - Fee Related CN102453036B (en) | 2010-10-27 | 2010-10-27 | A kind of camptothecine compounds and preparation method thereof and the purposes in agricultural chemicals |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102453036B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102670820B (en) * | 2012-05-29 | 2017-09-26 | 浙江农林大学 | Antibacterial medicament of a kind of external application containing camptothecine and its production and use |
CN103275095B (en) * | 2013-05-08 | 2015-07-22 | 中国农业科学院植物保护研究所 | 10-hydroxycamptothecine derivatives and applications thereof |
CN103275094B (en) * | 2013-05-08 | 2015-07-08 | 中国农业科学院植物保护研究所 | (20S)-camptothecin derivatives and application thereof |
CN104725390B (en) * | 2013-12-20 | 2017-04-05 | 兰州大学 | A kind of camptothecine compounds and preparation method thereof and the purposes in pesticide |
CN105295016B (en) * | 2014-07-16 | 2017-12-12 | 兰州大学 | It is a kind of to be used to kill medicine of agricultural pests and its production and use |
CN104387401A (en) * | 2014-11-28 | 2015-03-04 | 中国农业科学院植物保护研究所 | Camptothecin derivative and preparation method thereof |
CN105767018A (en) * | 2016-04-29 | 2016-07-20 | 山东胜伟园林科技有限公司 | Microbial pesticide for orange pest and disease control and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198164A (en) * | 1996-06-05 | 1998-11-04 | 雷迪博士研究基金会 | Novel water-soluble C-ring analogues of 20(s)-camptothecin |
US6177439B1 (en) * | 1995-06-06 | 2001-01-23 | Reddy's Research Foundation | Water soluble analogues of 20(S)-camptothecin |
EP1238678A1 (en) * | 2001-03-08 | 2002-09-11 | Bayer Aktiengesellschaft | Enzyme-activated cytostatic conjugates with integrin ligands |
WO2007140239A1 (en) * | 2006-05-24 | 2007-12-06 | Dr. Reddy's Laboratories Limited | Crystalline form of 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin |
WO2008148080A2 (en) * | 2007-05-24 | 2008-12-04 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin] |
-
2010
- 2010-10-27 CN CN201010520770.0A patent/CN102453036B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6177439B1 (en) * | 1995-06-06 | 2001-01-23 | Reddy's Research Foundation | Water soluble analogues of 20(S)-camptothecin |
CN1198164A (en) * | 1996-06-05 | 1998-11-04 | 雷迪博士研究基金会 | Novel water-soluble C-ring analogues of 20(s)-camptothecin |
EP1238678A1 (en) * | 2001-03-08 | 2002-09-11 | Bayer Aktiengesellschaft | Enzyme-activated cytostatic conjugates with integrin ligands |
WO2007140239A1 (en) * | 2006-05-24 | 2007-12-06 | Dr. Reddy's Laboratories Limited | Crystalline form of 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin |
CN101505599A (en) * | 2006-05-24 | 2009-08-12 | 雷迪博士实验室有限公司 | 5(S)-(2'-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the treatment of cancer |
WO2008148080A2 (en) * | 2007-05-24 | 2008-12-04 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin] |
Non-Patent Citations (1)
Title |
---|
Ying-Qian Liu等."First synthesis of novel spin-labeled derivatives of camptothecin as potential antineoplastic agents".《European Journal of Medicinal Chemistry》.2008,第43卷2610-2614. * |
Also Published As
Publication number | Publication date |
---|---|
CN102453036A (en) | 2012-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102453036B (en) | A kind of camptothecine compounds and preparation method thereof and the purposes in agricultural chemicals | |
JP2524688B2 (en) | Novel compound, method for producing the same and use thereof | |
ES2244004T3 (en) | ANTIPARASITARY AGENTS. | |
TWI609860B (en) | Novel cyclic ester peptide (Depsipeptide) derivatives and pest control agents containing the same | |
CN102948424A (en) | Boscalid-containing bactericidal composition | |
CN105295016B (en) | It is a kind of to be used to kill medicine of agricultural pests and its production and use | |
CN102633805B (en) | Chelerythrine alcoholate, preparation method thereof and application in plant fungicide medicaments | |
CN110590463B (en) | Fertilizer and snail-killing double-effect organic fertilizer and snail-killing agent, preparation method and application thereof | |
CN109422744A (en) | Matrine derivative and its synthesis and the application in terms of preventing and treating plant pest | |
CN102766146B (en) | Difurandihydrodihydro esters compound and application thereof to prepare insecticide | |
US10562911B2 (en) | Method for isolating flavonoids from rice plant inoculated with whitebacked planthopper | |
JP4176077B2 (en) | Novel FKI-1033 substance and production method thereof | |
CN103288810B (en) | Cyclopropyl derris hydrazide, and preparation method and application thereof | |
CN115785180B (en) | Spinosad derivatives as insecticides and preparation methods and uses thereof | |
CN101020678B (en) | Trisubstituted dihydro agarofuran compound and its pesticidal activity | |
CN114717119B (en) | A kind of grass coral endophytic fungus and its application | |
CN101961015B (en) | Application of toyocamycin in preventing and treating tomato early blight | |
CN104725390A (en) | Camptothecin compound, and preparation method and application thereof | |
CN102775417B (en) | Sanguinarine alcoholate, preparation method and application thereof in plant bactericide drug | |
CN112920194B (en) | Chromene coumarin derivative containing fluorine functional group and preparation method and application thereof | |
CN103833735A (en) | Compound for preventing and treating grape downy mildew and composition employing same | |
CN1323158C (en) | A insecticide and its application | |
CN113907082A (en) | Application of dithiine-tetracarboximide derivatives in preparation of bacteriostatic agent | |
CN109485683A (en) | Fluorine-containing serial avermectin derivatives of one kind and preparation method thereof | |
CN113831354A (en) | Dithiine-tetracarboximide derivatives, and preparation and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151202 Termination date: 20211027 |
|
CF01 | Termination of patent right due to non-payment of annual fee |